Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00770406
Other study ID # BTXA2008
Secondary ID
Status Recruiting
Phase Phase 1/Phase 2
First received October 9, 2008
Last updated August 3, 2009
Start date January 2009
Est. completion date June 2010

Study information

Verified date August 2009
Source Glostrup University Hospital, Copenhagen
Contact Soren Brostrom, MD, PhD
Phone +45-43232243
Email soren@brostrom.dk
Is FDA regulated No
Health authority Denmark: Ethics Committee
Study type Interventional

Clinical Trial Summary

A pilot study to examine efficacy and safety of intravesical botulinum toxin type A.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date June 2010
Est. primary completion date June 2010
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- refractory urge urinary incontinence

Exclusion Criteria:

- neurological disease

- pregnant or lactating

- bladder neoplasias

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Drug:
botulinum toxin type A
100 or 200 units intravesically

Locations

Country Name City State
Denmark Glostrup Hospital Glostrup Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
Glostrup University Hospital, Copenhagen

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incontinence episode frequency 1 year No
See also
  Status Clinical Trial Phase
Completed NCT01786967 - Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE) Phase 3
Enrolling by invitation NCT01940367 - Electrical Nerve Stimulation for Overactive Bladder a Comparison of Treatments N/A
Recruiting NCT00437528 - Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity Phase 1
Completed NCT04525105 - SMAD2, SMAD3 AND TGF-β GENE EXPRESSION IN URGE URINARY INCONTINENCE
Terminated NCT02129816 - Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder Phase 2/Phase 3
Terminated NCT01366066 - Transcutaneous Mechanical Nerve Stimulation in the Treatment of Incontinence Phase 3
Completed NCT01559389 - Incontinence & Intimate Partners: Assessing the Contribution of Treatment Phase 4
Completed NCT01166438 - Anticholinergic vs. Botox Comparison Study Phase 3
Completed NCT00909181 - Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence Phase 3
Terminated NCT03923348 - Pelvic Floor Muscle Training With Leva System for Urge Incontinence N/A
Completed NCT01445834 - Age-stratified Outcome of Pelvic Floor Muscle Exercise for Urinary Incontinence N/A
Completed NCT00498888 - The Long Term Outcomes of Rehabilitation and Drug Treatment for in Urgency Urinary Incontinence N/A
Terminated NCT00373789 - Refractory Urge Incontinence and Botox Injections Phase 3
Recruiting NCT01737411 - Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women Phase 1/Phase 2
Completed NCT00862745 - Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES) Phase 4
Completed NCT00177541 - Further Enhancing Non-pharmacologic Therapy for Incontinence N/A
Completed NCT02311634 - A Comparison of Electrical Pudendal Nerve Stimulation and Transvaginal Electrical Stimulation for Urge Incontinence N/A
Completed NCT01672190 - Lessening Incontinence by Learning Yoga N/A
Completed NCT01619995 - Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder N/A